Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Determine Central 5-HT1B Receptor Occupancy of ZOMIG® Rapimelt (Zolmitriptan) in Healthy Male Volunteers

This study has been completed.
Information provided by:
AstraZeneca Identifier:
First received: March 10, 2010
Last updated: November 2, 2010
Last verified: November 2010
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2010
  Primary Completion Date: October 2010 (Final data collection date for primary outcome measure)